UPDATE : Monday, September 7, 2020
상단여백
‘Body fluid management using BCM improves kidney function’ by Park Gi-taek 2017-09-12 08:26
Healthcare benefits for immune checkpoint inhibitor Tecentrqi, unclear by Park Gi-taek 2017-08-30 10:17
When can we hear about the conquest of liver cancer? by Park Gi-taek 2017-08-29 07:00
‘Let's protect patients until complete cure of hepatitis B comes’ by Park Gi-taek 2017-08-28 10:46
Drugmakers cut entertainment expense due to anticorruption law by Park Gi-taek 2017-08-25 16:27
라인
‘Moon Jae-in care’ keeps industry busy weighing bottom lines by Park Gi-taek 2017-08-11 13:42
New osteoporosis therapy causes curiosity about drug price by Park Gi-taek 2017-08-07 14:42
‘Neither handouts nor patient complaints give insurance benefits to expensive drugs’ by Park Gi-taek 2017-07-24 20:28
CEOs of foreign pharmaceuticals don't seem to regard Korean employees as colleagues by Park Gi-taek 2017-07-13 18:20
Castleman’s disease patients suffer from high drug prices by Park Gi-taek 2017-07-11 17:00
라인
First patient resistant to Viread found in Korea by Park Gi-taek 2017-06-26 13:40
Is personalized cancer treatment using NGS unavailable in Korea? by Park Gi-taek 2017-06-22 18:19
‘Korean version of NOAC guidelines may come out before long’ by Park Gi-taek 2017-06-20 17:52
‘Early diagnosis necessary for treating rare Gaucher's disease’ by Park Gi-taek 2017-06-19 20:22
Introduction of DAA changed treatment of Hepatitis C by Park Gi-taek 2017-06-07 16:43
라인
Gilead’s new hepatitis B therapy in controversy due to side effects by Park Gi-taek 2017-05-31 17:04
Gilead Sciences keeps on rolling in Korea: Why? by Park Gi-taek 2017-05-11 14:52
Can Jardiance threaten Forxiga's dominance in treating diabetes? by Park Gi-taek 2017-05-04 13:30
‘We must move beyond completely curing Hepatitis C to eradicating it’ by Park Gi-taek 2017-04-18 14:47
Will post-mass infection anti-HCV measures prove to be sufficient? by Park Gi-taek 2017-04-17 16:49
여백
여백
여백
Back to Top